351 related articles for article (PubMed ID: 32245401)
21. Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis.
Kerur B; Litman HJ; Stern JB; Weber S; Lightdale JR; Rufo PA; Bousvaros A
World J Gastroenterol; 2017 May; 23(18):3322-3329. PubMed ID: 28566893
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of mucosal healing of ulcerative colitis by a quantitative fecal immunochemical test.
Nakarai A; Kato J; Hiraoka S; Kuriyama M; Akita M; Hirakawa T; Okada H; Yamamoto K
Am J Gastroenterol; 2013 Jan; 108(1):83-9. PubMed ID: 23007005
[TBL] [Abstract][Full Text] [Related]
23. Importance of mucosal healing in ulcerative colitis.
Lichtenstein GR; Rutgeerts P
Inflamm Bowel Dis; 2010 Feb; 16(2):338-46. PubMed ID: 19637362
[TBL] [Abstract][Full Text] [Related]
24. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
[TBL] [Abstract][Full Text] [Related]
25. A [Glyco]biomarker that Predicts Failure to Standard Therapy in Ulcerative Colitis Patients.
Pereira MS; Maia L; Azevedo LF; Campos S; Carvalho S; Dias AM; Albergaria A; Lima J; Marcos-Pinto R; Lago P; Pinho SS
J Crohns Colitis; 2019 Jan; 13(1):39-49. PubMed ID: 30239648
[TBL] [Abstract][Full Text] [Related]
26. Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.
Nakarai A; Kato J; Hiraoka S; Inokuchi T; Takei D; Moritou Y; Akita M; Takahashi S; Hori K; Harada K; Okada H; Yamamoto K
World J Gastroenterol; 2014 Dec; 20(48):18367-74. PubMed ID: 25561804
[TBL] [Abstract][Full Text] [Related]
27. Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse.
Nakarai A; Kato J; Hiraoka S; Takashima S; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H
World J Gastroenterol; 2016 Jun; 22(21):5079-87. PubMed ID: 27275100
[TBL] [Abstract][Full Text] [Related]
28. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Colombel JF; Rutgeerts P; Reinisch W; Esser D; Wang Y; Lang Y; Marano CW; Strauss R; Oddens BJ; Feagan BG; Hanauer SB; Lichtenstein GR; Present D; Sands BE; Sandborn WJ
Gastroenterology; 2011 Oct; 141(4):1194-201. PubMed ID: 21723220
[TBL] [Abstract][Full Text] [Related]
29. Can we predict mucosal remission in ulcerative colitis more precisely with a redefined cutoff level of C-reactive protein?
Bakkaloglu OK; Eskazan T; Celik S; Kurt EA; Hatemi I; Erzin Y; Celik AF
Colorectal Dis; 2022 Jan; 24(1):77-84. PubMed ID: 34610199
[TBL] [Abstract][Full Text] [Related]
30. Serum human trefoil factor 3 is a biomarker for mucosal healing in ulcerative colitis patients with minimal disease activity.
Srivastava S; Kedia S; Kumar S; Pratap Mouli V; Dhingra R; Sachdev V; Tiwari V; Kurrey L; Pradhan R; Ahuja V
J Crohns Colitis; 2015 Jul; 9(7):575-9. PubMed ID: 25964429
[TBL] [Abstract][Full Text] [Related]
31. Utility of the Serum-Based Endoscopic Healing Index in Monitoring Therapeutic Response in Ulcerative Colitis.
Alsoud D; Ho J; Sabino J; Ferrante M; Vermeire S; Verstockt B
Am J Gastroenterol; 2024 Mar; 119(3):477-485. PubMed ID: 37753938
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study.
Barreiro-de Acosta M; Vallejo N; de la Iglesia D; Uribarri L; Bastón I; Ferreiro-Iglesias R; Lorenzo A; Domínguez-Muñoz JE
J Crohns Colitis; 2016 Jan; 10(1):13-9. PubMed ID: 26351390
[TBL] [Abstract][Full Text] [Related]
33. Confocal laser endomicroscopy in ulcerative colitis: a longitudinal study of endomicroscopic changes and response to medical therapy (with videos).
Karstensen JG; Săftoiu A; Brynskov J; Hendel J; Ciocalteu A; Klausen P; Klausen TW; Riis LB; Vilmann P
Gastrointest Endosc; 2016 Aug; 84(2):279-286.e1. PubMed ID: 26945556
[TBL] [Abstract][Full Text] [Related]
34. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
[TBL] [Abstract][Full Text] [Related]
35. Serum Globulin Is Associated with Endoscopic Findings and Mucosal Healing in Japanese Patients with Ulcerative Colitis.
Shiraishi K; Furukawa S; Yagi S; Mori K; Ninomiya T; Kawasaki K; Mizukami Y; Suzuki S; Uraoka M; Shibata N; Nakamura S; Imamine S; Murakami H; Ohashi K; Torisu M; Yano M; Hasebe A; Yano H; Murakami M; Takeshita E; Ikeda Y; Hiasa Y
Dig Dis Sci; 2022 Jan; 67(1):233-240. PubMed ID: 33537920
[TBL] [Abstract][Full Text] [Related]
36. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
[TBL] [Abstract][Full Text] [Related]
37. Histological healing after infliximab induction therapy in children with ulcerative colitis.
Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J
World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025
[TBL] [Abstract][Full Text] [Related]
38. Increased suppressor of cytokine signaling-3 expression predicts mucosal relapse in ulcerative colitis.
Li Y; Nuij VJ; Baars JE; Biermann K; Kuipers EJ; Peppelenbosch MP; de Haar C; Janneke van der Woude C
Inflamm Bowel Dis; 2013 Jan; 19(1):132-40. PubMed ID: 22535619
[TBL] [Abstract][Full Text] [Related]
39. A randomized clinical trial of mesalazine suppository: the usefulness and problems of central review of evaluations of colonic mucosal findings.
Kobayashi K; Hirai F; Naganuma M; Watanabe K; Ando T; Nakase H; Matsuoka K; Watanabe M
J Crohns Colitis; 2014 Nov; 8(11):1444-53. PubMed ID: 24923656
[TBL] [Abstract][Full Text] [Related]
40. Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD.
Molander P; Sipponen T; Kemppainen H; Jussila A; Blomster T; Koskela R; Nissinen M; Rautiainen H; Kuisma J; Kolho KL; Färkkilä M
J Crohns Colitis; 2013 Oct; 7(9):730-5. PubMed ID: 23182163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
